# Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

> **NCT00724061** · NA · TERMINATED · sponsor: **Northwestern University** · enrollment: 7 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** Pegylated interferon α-2b
- **OTHER:** Psoralens with ultraviolet light A
- **OTHER:** Narrowband-ultraviolet light B

## Key facts

- **NCT ID:** NCT00724061
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Closed early due to poor accrual.
- **Last updated:** 2018-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724061, "Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00724061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*